AIkido Pharma Inc. (AIKI) Financials

NASDAQ Currency in USD Disclaimer

$3.56

north_east NA Past Year
Day's range
$3.5
Day's range
$3.66
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning2016201620172017201820182019201920202020202120212022202220000%20000%0%0%-20000%-20000%-40000%-40000%-60000%-60000%Profit Margin
Profit Margin
Revenue
Earnings

AIKI Income statement / Annual

Last year (2022), AIkido Pharma Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2022, AIkido Pharma Inc.'s net income was -$29.87 M. See AIkido Pharma Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $0.00 $0.00 $0.00 $9,000.00 $28,000.00 $1.24 M $877,000.00 $33,000.00 $10,000.00 $27,000.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $81,000.00 $92,000.00 $84,000.00 $88,000.00 $864,000.00 $3,000.00
Gross Profit $0.00 $0.00 $0.00 $9,000.00 -$53,000.00 $1.14 M $793,000.00 -$55,000.00 -$854,000.00 $24,000.00
Gross Profit Ratio 0 0 0 1 -1.89 0.93 0.9 -1.67 -85.4 0.89
Research and Development Expenses $830,000.00 $559,000.00 $2.49 M $2.52 M $0.00 $0.00 $0.00 $0.00 $0.00 $10,000.00
General & Administrative Expenses $11.68 M $7.73 M $4.06 M $0.00 $3.06 M $3.69 M $4.58 M $5.13 M $20.79 M $15.07 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $11.68 M $7.73 M $4.06 M $3.17 M $3.06 M $3.69 M $4.58 M $5.13 M $20.79 M $15.07 M
Other Expenses $1.83 M $1.15 M $1.47 M $0.00 $1.44 M $1.37 M $2.14 M $6.32 M $9.83 M $291,000.00
Operating Expenses $14.35 M $9.44 M $6.55 M $5.69 M $4.50 M $5.06 M $6.72 M $11.44 M $30.62 M $15.37 M
Cost And Expenses $14.35 M $9.44 M $6.55 M $5.69 M $4.50 M $5.06 M $6.72 M $11.44 M $30.62 M $15.37 M
Interest Income $687,000.00 $252,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $7.76 M -$2.27 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization -$188,000.00 $2.27 M -$5.79 M $1.50 M $1.44 M $1.38 M $2.14 M $6.32 M $9.83 M $291,000.00
EBITDA -$14.35 M -$7.17 M -$12.34 M -$4.18 M $3.17 M -$1.93 M -$4.34 M -$45.15 M -$20.70 M -$17.67 M
EBITDA Ratio 0 0 0 -464.78 113.21 -1.56 -4.95 -1368.09 -2070.1 -654.59
Operating Income Ratio 0 0 0 -631.67 -245.5 -3.09 -9.75 -1576.06 -3061.1 -568.41
Total Other Income/Expenses Net -$7.76 M $2.27 M -$5.79 M $1.50 M $8.60 M $516,000.00 $2.08 M $545,000.00 $79,000.00 -$2.62 M
Income Before Tax -$22.11 M -$7.17 M -$12.34 M -$4.18 M $1.73 M -$3.31 M -$6.48 M -$51.47 M -$30.53 M -$17.97 M
Income Before Tax Ratio 0 0 0 -464.78 61.68 -2.67 -7.38 -1559.55 -3053.2 -665.37
Income Tax Expense $7.76 M -$2.27 M $0.00 $0.00 $8.60 M $516,000.00 $2.08 M $545,000.00 $79,000.00 -$2.62 M
Net Income -$29.87 M -$4.90 M -$12.34 M -$4.18 M $1.73 M -$3.31 M -$6.48 M -$51.47 M -$30.53 M -$17.97 M
Net Income Ratio 0 0 0 -464.78 61.68 -2.67 -7.38 -1559.55 -3053.2 -665.37
EPS -5.6 -2.97 -7.47 -28.31 15.48 -43.13 -126.45 -2195.79 -2123.52 -18733.06
EPS Diluted -5.6 -2.97 -7.47 -28.31 15.48 -43.13 -121.9 -2195.79 -2123.52 -18733.06
Weighted Average Shares Out $5.33 M $1.65 M $1.65 M $147,739.00 $111,572.00 $76,658.00 $51,212.00 $23,438.00 $14,378.00 $959.00
Weighted Average Shares Out Diluted $5.33 M $1.65 M $1.65 M $147,739.00 $111,572.00 $76,658.00 $53,126.00 $23,438.00 $14,378.00 $959.00
Link